FDA-Approved Uses in the USA In the United States, semaglutide is marketed under three main brand names, each approved for specific conditions: Wegovy: Specifically FDA-approved for chronic weight management in adults with obesity or overweight individuals with at least one weight-related condition (like high blood pressure)
in these cases, injections are typically required
Conditions such as vitamin deficiencies, medication interactions, or unrelated oral or neurological conditions can cause taste disturbances and should be considered in the differential diagnosis
However, the peptide characteristics that enable absorption through the gastric mucosa, including its stability in acidic environments and resistance to enzymatic degradation, suggest it should maintain activity when absorbed through nasal mucosa as well
Plasma SPARC levels positively correlate with lumbar spine BMD, and 12 months of recombinant human parathyroid hormone (134) treatment in osteoporotic patients increases the circulating SPARC level, which is associated with changes in lumbar BMD at L2-L4 [24]
Data like this could play an important role in shifting how obesity treatment is viewedboth clinically and by insurers, Ali noted to MNT
